CancerLinQ LLC, an initiative of the American Society of Clinical Oncology, announced a long-term partnership with FDA that will rely on cancer patient information and big data analytics to examine the real-world use of emerging and newly approved cancer therapies.
The Biden administration has left NIH in a weakened state, intensifying politicization of science on Capitol Hill and eroding the bipartisan support the government’s premier biomedical research agency has traditionally enjoyed.
